How many insider trades does FilingIQ track for AIDX?

FilingIQ tracks 13 Form 4 insider transactions for AIDX (20/20 Biolabs, Inc.), covering filings from Feb 19, 2026 onwards. 13 of those were filed in the last 90 days.

Are AIDX insiders net buyers or net sellers?

Across the full Form 4 history for AIDX, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does AIDX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is AIDX in?

20/20 Biolabs, Inc. (AIDX) is classified in the Healthcare sector, specifically Medical Devices.

AIDX insider trading

NasdaqCM Healthcare

20/20 Biolabs, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

0% / 0%

Market cap

—

About 20/20 Biolabs, Inc.

20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (CLIAx), a shared laboratory facility that supports diagnostic test developers in bringing products to the U.S. market. The company also delivers its cancer screening algorithm technology through a software as a service (SaaS) platform in partnership with healthcare providers and supports diagnostic startups by offering access to shared laboratory space and resources. The company was founded in 2000 and is based in Gaithersburg, Maryland.

Company website: 2020biolabs.com

AIDX insider activity at a glance

FilingIQ has scored 13 insider transactions for AIDX since Feb 19, 2026. The most recent filing in our index is dated Apr 2, 2026.

Across the full history, 0 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

View live AIDX trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for AIDX?: FilingIQ tracks 13 Form 4 insider transactions for AIDX (20/20 Biolabs, Inc.), covering filings from Feb 19, 2026 onwards. 13 of those were filed in the last 90 days.
Are AIDX insiders net buyers or net sellers?: Across the full Form 4 history for AIDX, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does AIDX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is AIDX in?: 20/20 Biolabs, Inc. (AIDX) is classified in the Healthcare sector, specifically Medical Devices.

Methodology & sources

Every AIDX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.